MarketBeat Flags Hut 8, Tempus AI, SoundHound as Top AI Stocks by Trading Volume
Hut 8, Tempus AI and SoundHound AI show highest AI stock trading volume; see price moves, market caps and what to watch next.
Visual sourcing
No source-linked image is attached to this story yet. Measured Take avoids generic stock art when a relevant credited image is not available.
TL;DR: **MarketBeat’s screener identified Hut 8 (HUT), Tempus AI (TEM) and SoundHound AI (SOUN) as the AI stocks with the greatest dollar trading volume in recent sessions.**
**Context** Artificial intelligence stocks represent companies whose core products or services rely on AI development, deployment or commercialization. Hut 8 operates data centers that support AI workloads alongside cryptocurrency mining. Tempus AI provides AI‑enabled precision‑medicine tools to clinicians, helping tailor cancer and other treatments. SoundHound AI builds voice‑AI platforms for automotive, TV, IoT and customer‑service applications, offering APIs, custom assistants and analytics.
**Key Facts** - Hut 8 shares rose 2.4% to $10.80, giving the firm a market capitalization of roughly $1.3 billion. - Tempus AI gained 1.9% to $45.20, valuing the company near $6 billion. - SoundHound AI advanced 3.1% to $4.10, with a market cap of about $800 million. - The three stocks posted the highest dollar trading volume among AI‑focused equities over the past several days, outpacing peers such as those in the Global X Artificial Intelligence & Technology ETF (AIQ), which was up 0.8% over the same period. - Hut 8 carries a Moderate Buy rating from the analyst consensus, yet MarketBeat notes that top‑rated analysts currently recommend five other stocks as better buys.
**What It Means** Elevated trading volume often signals heightened investor interest or reaction to news, though it does not guarantee price direction. Hut 8’s business model ties AI exposure to its data‑center rental revenue, which fluctuates with demand for high‑performance computing. Tempus AI’s growth depends on adoption of its clinical AI tools by hospitals and pharmaceutical firms. SoundHound’s prospects hinge on licensing its voice‑AI platform to device makers and service providers. Investors should monitor upcoming quarterly earnings reports, any new AI‑related contracts, and broader trends in AI infrastructure spending to gauge whether the current volume reflects sustained conviction or short‑term speculation.
Conversation
Reader notes
Loading comments...